These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33867227)

  • 1. Corrigendum to "Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities" [Bioorg. Med. Chem. Lett. 20(23) (2010) 7110-7115].
    Liang C; Ding Y; Nguyen HT; Kim JA; Boo HJ; Kang HK; Nguyen MC; Kim YH
    Bioorg Med Chem Lett; 2021 Jun; 41():128014. PubMed ID: 33867227
    [No Abstract]   [Full Text] [Related]  

  • 2. Oleanane-triterpenoids from Panax stipuleanatus inhibit NF-κB.
    Liang C; Ding Y; Song SB; Kim JA; Cuong NM; Ma JY; Kim YH
    J Ginseng Res; 2013 Mar; 37(1):74-9. PubMed ID: 23717159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities.
    Liang C; Ding Y; Nguyen HT; Kim JA; Boo HJ; Kang HK; Nguyen MC; Kim YH
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7110-5. PubMed ID: 20951582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus" [Bioorg. Med. Chem. Lett. 27 (2017) 893-896].
    Zhou J; Feng JH; Robertson J; Fang L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127294. PubMed ID: 32518059
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Syntheses and antimicrobial activities of ogipeptin derivatives" [Bioorg. Med. Chem. Lett. 42 (2021) 128093].
    Takiguchi S; Homma H; Fujisawa T; Hirota-Takahata Y; Ono Y; Kizuka M; Ishii Y; Yoshimura S; Nishi T
    Bioorg Med Chem Lett; 2021 Sep; 47():128228. PubMed ID: 34192636
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Novel NanoLuc-type substrates with various C-6 substitutions" [Bioorg. Med. Chem. Lett. 30 (2020) 127085].
    Yan C; Du L; Li M
    Bioorg Med Chem Lett; 2021 May; 39():127940. PubMed ID: 33677042
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
    Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96].
    Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998].
    Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486].
    Mastracchio A; Lai C; Torrent M; Bromberg K; Buchanan FG; Ferguson D; Bontcheva V; Johnson EF; Lasko L; Maag D; Shoemaker AR; Penning TD
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126895. PubMed ID: 31926787
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580].
    Fradera X; Methot JL; Achab A; Christopher M; Altman MD; Zhou H; McGowan MA; Kattar SD; Wilson K; Garcia Y; Augustin MA; Lesburg CA; Shah S; Goldenblatt P; Katz JD
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127363. PubMed ID: 32591133
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535].
    Hartung AM; Navarro HA; Wiemer DF; Neighbors JD
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Oxa-adamantyl cannabinoids" [Bioorg. Med. Chem. Lett. 38 (2021) 127882].
    Ho TC; Mullins JJ; Tius MA; Nikas SP; Tran NK; Tong F; Zvonok N; Makriyannis A
    Bioorg Med Chem Lett; 2022 Sep; 72():128836. PubMed ID: 35803774
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].
    Grädler U; Busch M; Leuthner B; Raba M; Burgdorf L; Lehmann M; Linde N; Esdar C
    Bioorg Med Chem Lett; 2021 Oct; 49():128262. PubMed ID: 34352662
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
    Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
    Kim SH; Johnson JA; Jiang J; Parkhurst B; Phillips M; Pi Z; Qiao JX; Tora G; Ye Chen A; Liu E; Yin X; Yang R; Zhao L; Taylor DS; Basso M; Behnia K; Onorato J; Chen XQ; Abell LM; Lu H; Locke G; Caporuscio C; Adam LP; Gordon D; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2525. PubMed ID: 31353296
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
    Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126771. PubMed ID: 31859161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.